TableĀ 1

Demographic and clinical characteristics of patients at initial presentation

Clinical characteristicsamnestic AD (n=29)PCA (n=12)lvPPA (n=12)bvFTD (n=20)nfvPPA (n=7)svPPA (n=6)SCI (n=25)
Age (years)63.9a (8.4)61.4 (6.2)69.2c (8.7)61.7 (8.4)67.0 (7.6)68.2a (7.6)57.4 (7.2)
Education (years)13.3* (2.7)11.9 (1.9)12.1 (2.5)12.8 (2.6)12.7 (2.6)12.7 (2.7)13.2 (2.8)
Symptom duration (years)2.3* (1.3)2.2 (0.79)2.2* (0.85)2.6 (2.2)2.6 (2.1)1.6 (0.77)2.8 (2.8)
ACE attention and orientation (18)12.9d (3.4)13.8a (3.9)12.4 (5.9)14.8 (3.6)16.6 (3.1)17.8 (0.5)17.7 (0.47)
ACE memory (26)11.6d (4.2)16.3b (6.8)10.9d (9.2)15.1d (6.0)19.0 (6.6)17.8 (4.2)23.5 (3.2)
ACE fluency (14)6.3d (3.1)8.6 (3.8)6.0c (4.8)5.1d (3.6)5.2b (3.8)6.5 (1.3)11.6 (1.9)
ACE language (26)22.0a,h (3.8)20.3b (4.1)15.7d (6.8)20.2c (4.9)20.8 (4.0)16.5b (2.9)25.7 (0.66)
ACE visuospatial (16)11.2d,e (3.9)7.6d (4.8)12.9f (3.0)13.4g (2.9)15.8g (0.5)15.8g (0.5)15.9 (0.49)
ACE total (100)65.5d* (14.5)66.7d (16.5)57.6d* (27.0)69.0d* (16.2)76.8* (15.5)74.5* (6.0)94.6 (3.3)
  • Significant difference compared to aSCI p<0.05; bSCI p<0.01; cSCI p<0.001; dSCI p<0.0001; ePCA p<0.05; fPCA p<0.01; gPCA p<0.0001; hlvPPA p<0.001.

  • *Missing data: Education level not recorded for 3 patients with amnestic AD; symptom duration not available for 1 lvPPA and 1 patients with amnestic AD as they presented alone; ACE not completed in 2 lvPPA, 1 amnestic AD, 1 bvFTD, 2 nfvPPA and 2 svPPA due to either refusal by patient or clinicians decision not to test due to patient severity/anxiety.

  • ACE, Addenbrooke's Cognitive Examination; AD, Alzheimer's disease; bvFTD, behavioural variant frontotemporal dementia; lvPPA, logopenic variant primary progressive aphasia; nfvPPA, non-fluent variant primary progressive aphasia; PCA, posterior cortical atrophy; SCI, subjective cognitive impairment; svPPA, semantic variant primary progressive aphasia.